Utilidad de los marcadores bioquímicos de preeclampsia

  1. María José Alcaine Villarroya 1
  2. Eva Mª Barrenechea 1
  3. Elena Casals
  4. Concepción González Rodríguez 1
  5. Inmaculada Martín Navas 1
  6. Hada C. Macher 1
  7. Mª Concepción Martínez 1
  8. Daniel Morell Garcia 2
  9. Helena Méndez 2
  10. Irene Rosas Allende 1
  11. Elvira Tejedor 1
  12. Mª Belén Prieto García
  1. 1 Comisión de Diagnóstico Prenatal, Sociedad Española de Medicina de Laboratorio, Barcelona, España
  2. 2 Servicio de Análisis Clínicos, Hospital Universitario Son Espases, Palma de Mallorca, España
Zeitschrift:
Revista del laboratorio clínico

ISSN: 1888-4008

Datum der Publikation: 2019

Ausgabe: 12

Nummer: 3

Seiten: 9-24

Art: Artikel

DOI: HTTPS://DOI.ORG/10.1016/J.LABCLI.2018.06.001 DIALNET GOOGLE SCHOLAR

Andere Publikationen in: Revista del laboratorio clínico

Zusammenfassung

Pre-eclampsia (PE) is one of the leading causes of maternal and perinatal mortality in the world. In developed countries, studies point to a significant increase in the incidence of PE in the last decade, partly due to the increase in the prevalence in the general population of diseases that affect vascular function, such as diabetes. chronic hypertension, or kidney disease. An updated review of PE is presented in this article. The diagnostic criteria and the pathophysiology of the disease are described. The main objective of the document is to review the new biochemical markers that may be useful in clinical practice for the prediction and diagnosis of PE, as well as the different methods by which yey can be determined.

Fuente de los datos: Dialnet